Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/2
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Jun 03, 2024Jun 04, 2024Spiegelman Daniel K
Dir
SellMyriad Genetics IncMYGN$22.05$167,013-18.71%
Jun 02, 2023Jun 02, 2023Spiegelman Daniel K
Dir
SellMyriad Genetics IncMYGN$23.01$198,760-17.58%
Jun 06, 2022Jun 06, 2022Spiegelman Daniel K
Dir
SellMyriad Genetics IncMYGN$19.25$123,673-15.90%
Jun 17, 2021Jun 17, 2021Spiegelman Daniel K
Dir
SellMyriad Genetics IncMYGN$30.52$95,795-11.95%
May 28, 2021Jun 01, 2021Spiegelman Daniel K
Dir
SellMyriad Genetics IncMYGN$28.99$207,023-34.73%
Apr 01, 2019Apr 03, 2019Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$89$1M-22.09%
Mar 27, 2019Mar 29, 2019Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$90$9,000-0.16%
Jun 22, 2018Jun 27, 2018Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$99$990,005-16.37%
Apr 23, 2018Apr 26, 2018Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$82.15$908,497-15.03%
May 27, 2015Oct 14, 2017Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$130$4M-31.08%
Mar 16, 2017Mar 17, 2017Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$91.96$182,908-12.08%
Mar 06, 2017Mar 09, 2017Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$93.32$214,916-9.99%
Feb 28, 2017Mar 02, 2017Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$94.07$3M-58.00%
Jan 09, 2017Jan 10, 2017Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$90$450,000-21.65%
Nov 09, 2016Nov 14, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$90.61$2M-46.40%
Aug 01, 2016Aug 03, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$99.33$397,320-8.52%
Jun 06, 2016Jun 09, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$89.14$146,992-3.39%
Jun 07, 2016Jun 08, 2016Spiegelman Daniel K
Dir
SellRelypsa IncRLYP$19.31$19,562-45.02%
May 31, 2016Jun 02, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$89.88$2M-29.26%
May 23, 2016May 25, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$87.07$328,184-6.04%
Mar 02, 2016Mar 03, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$86.12$398,120-8.51%
Nov 16, 2015Nov 18, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$104.3$2M-41.47%
Jun 05, 2015Jun 08, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$122.3$201,669-5.52%
May 29, 2015Jun 04, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$124.73$688,876-14.85%
May 18, 2015May 28, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$130$4M-45.09%
May 18, 2015May 19, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$124.77$256,905-2.65%
Mar 25, 2015Apr 02, 2015Spiegelman Daniel K
Dir
BuyOncothyreon Inc.ONTY$1.61$32,127+32.98%
Mar 25, 2015Apr 01, 2015Spiegelman Daniel K
Dir
BuyOncothyreon Inc.ONTY$1.61$32,127+32.98%
Mar 02, 2015Mar 05, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$107$2M-18.41%
Mar 05, 2014Feb 10, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$70.61$2,895-0.06%